{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:32:03Z","timestamp":1789147923282,"version":"build-2803163510"},"reference-count":50,"publisher":"American Diabetes Association","issue":"10","license":[{"start":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T00:00:00Z","timestamp":1623110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/content\/license"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,10,1]]},"abstract":"<jats:p>Inflammation and abnormal metabolism play important roles in the pathogenesis of diabetic nephropathy (DN). Annexin A1 (ANXA1) contributes to inflammation resolution and improves metabolism. In this study, we assess the effects of ANXA1 in diabetic mice and proximal tubular epithelial cells (PTECs) treated with high glucose plus palmitate acid (HGPA) and explore the association of ANXA1 with lipid accumulation in patients with DN. It is found that ANXA1 deletion aggravates renal injuries, including albuminuria, mesangial matrix expansion, and tubulointerstitial lesions in high-fat diet\/streptozotocin\u2013induced diabetic mice. ANXA1 deficiency promotes intrarenal lipid accumulation and drives mitochondrial alterations in kidneys. In addition, Ac2-26, an ANXA1 mimetic peptide, has a therapeutic effect against lipid toxicity in diabetic mice. In HGPA-treated human PTECs, ANXA1 silencing causes FPR2\/ALX-driven deleterious effects, which suppress phosphorylated Thr172 AMPK, resulting in decreased peroxisome proliferator\u2013activated receptor \u03b1 and carnitine palmitoyltransferase 1b expression and increased HGPA-induced lipid accumulation, apoptosis, and elevated expression of proinflammatory and profibrotic genes. Last but not least, the extent of lipid accumulation correlates with renal function, and the level of tubulointerstitial ANXA1 expression correlates with ectopic lipid deposition in kidneys of patients with DN. These data demonstrate that ANXA1 regulates lipid metabolism of PTECs to ameliorate disease progression; hence, it holds great potential as a therapeutic target for DN.<\/jats:p>","DOI":"10.2337\/db21-0050","type":"journal-article","created":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T11:55:40Z","timestamp":1623153340000},"page":"2192-2203","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":113,"title":["The Attenuation of Diabetic Nephropathy by Annexin A1 via Regulation of Lipid Metabolism Through the AMPK\/PPAR\u03b1\/CPT1b Pathway"],"prefix":"10.2337","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6904-259X","authenticated-orcid":false,"given":"Liang","family":"Wu","sequence":"first","affiliation":[{"name":"Renal Division, Department of Medicine, Peking University First Hospital; Institute of Nephrology, Peking University, Key Laboratory of Renal Disease, Ministry of Health of China; Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education, Beijing, China"},{"name":"Research Units of Diagnosis and Treatment of Immune-Mediated Kidney Diseases, Chinese Academy of Medical Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changjie","family":"Liu","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Sciences, Institute of Systems Biomedicine, School of Basic Medical Sciences, Key Laboratory of Molecular Cardiovascular Science, Ministry of Education; Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides, Ministry of Health, Beijing Key Laboratory of Cardiovascular Receptors Research, Peking University Health Science Center, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Yuan","family":"Chang","sequence":"additional","affiliation":[{"name":"Renal Division, Department of Medicine, Peking University First Hospital; Institute of Nephrology, Peking University, Key Laboratory of Renal Disease, Ministry of Health of China; Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education, Beijing, China"},{"name":"Research Units of Diagnosis and Treatment of Immune-Mediated Kidney Diseases, Chinese Academy of Medical Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhan","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Sciences, Institute of Systems Biomedicine, School of Basic Medical Sciences, Key Laboratory of Molecular Cardiovascular Science, Ministry of Education; Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides, Ministry of Health, Beijing Key Laboratory of Cardiovascular Receptors Research, Peking University Health Science Center, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingming","family":"Zhao","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Sciences, Institute of Systems Biomedicine, School of Basic Medical Sciences, Key Laboratory of Molecular Cardiovascular Science, Ministry of Education; Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides, Ministry of Health, Beijing Key Laboratory of Cardiovascular Receptors Research, Peking University Health Science Center, Beijing, China"},{"name":"Department of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sin","family":"Man Lam","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Molecular Developmental Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China"},{"name":"Lipidall Technologies Co., Ltd., Changzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1621-9643","authenticated-orcid":false,"given":"Guanghou","family":"Shui","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Molecular Developmental Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Hui","family":"Zhao","sequence":"additional","affiliation":[{"name":"Renal Division, Department of Medicine, Peking University First Hospital; Institute of Nephrology, Peking University, Key Laboratory of Renal Disease, Ministry of Health of China; Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education, Beijing, China"},{"name":"Research Units of Diagnosis and Treatment of Immune-Mediated Kidney Diseases, Chinese Academy of Medical Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4473-6936","authenticated-orcid":false,"given":"Lemin","family":"Zheng","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Sciences, Institute of Systems Biomedicine, School of Basic Medical Sciences, Key Laboratory of Molecular Cardiovascular Science, Ministry of Education; Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides, Ministry of Health, Beijing Key Laboratory of Cardiovascular Receptors Research, Peking University Health Science Center, Beijing, China"},{"name":"Beijing Tiantan Hospital, China National Clinical Research Center for Neuro-logical Diseases, Advanced Innovation Center for Human Brain Protection, The Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6413-6973","authenticated-orcid":false,"given":"Min","family":"Chen","sequence":"additional","affiliation":[{"name":"Renal Division, Department of Medicine, Peking University First Hospital; Institute of Nephrology, Peking University, Key Laboratory of Renal Disease, Ministry of Health of China; Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education, Beijing, China"},{"name":"Research Units of Diagnosis and Treatment of Immune-Mediated Kidney Diseases, Chinese Academy of Medical Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2021,6,8]]},"reference":[{"key":"2022031309301527400_B1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrneph.2011.51","article-title":"Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy","volume":"7","author":"Navarro-Gonz\u00e1lez","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"2022031309301527400_B2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11892-019-1143-4","article-title":"The interconnection between immuno-metabolism, diabetes, and CKD","volume":"19","author":"Bonacina","year":"2019","journal-title":"Curr Diab Rep"},{"key":"2022031309301527400_B3","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/278456a0","article-title":"Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation","volume":"278","author":"Flower","year":"1979","journal-title":"Nature"},{"key":"2022031309301527400_B4","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3389\/fimmu.2012.00354","article-title":"Annexin A1 and the regulation of innate and adaptive immunity","volume":"3","author":"Gavins","year":"2012","journal-title":"Front Immunol"},{"key":"2022031309301527400_B5","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nrrheum.2013.126","article-title":"Annexin A1: potential for glucocorticoid sparing in RA","volume":"9","author":"Yang","year":"2013","journal-title":"Nat Rev Rheumatol"},{"key":"2022031309301527400_B6","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.3390\/ijms20143449","article-title":"Annexins in adipose tissue: novel players in obesity","volume":"20","author":"Grewal","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2022031309301527400_B7","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3389\/fimmu.2019.00571","article-title":"Identification of AnnexinA1 as an endogenous regulator of RhoA, and its role in the pathophysiology and experimental therapy of type-2 diabetes","volume":"10","author":"Purvis","year":"2019","journal-title":"Front Immunol"},{"key":"2022031309301527400_B8","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2337\/db15-0990","article-title":"Annexin A1 is a key modulator of mesenchymal stromal cell-mediated improvements in islet function","volume":"65","author":"Rackham","year":"2016","journal-title":"Diabetes"},{"key":"2022031309301527400_B9","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1042\/CS20171251","article-title":"Mesenchymal stromal cells improve human islet function through released products and extracellular matrix","volume":"131","author":"Arzouni","year":"2017","journal-title":"Clin Sci (Lond)"},{"key":"2022031309301527400_B10","doi-asserted-by":"crossref","first-page":"e82608","DOI":"10.1371\/journal.pone.0082608","article-title":"Increased adiposity in annexin A1-deficient mice","volume":"8","author":"Akasheh","year":"2013","journal-title":"PLoS One"},{"key":"2022031309301527400_B11","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s00125-017-4469-y","article-title":"Annexin A1 attenuates microvascular complications through restoration of Akt signalling in a murine model of type 1 diabetes","volume":"61","author":"Purvis","year":"2018","journal-title":"Diabetologia"},{"key":"2022031309301527400_B12","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1534\/genetics.113.156570","article-title":"Highly efficient targeted mutagenesis in mice using TALENs","volume":"195","author":"Panda","year":"2013","journal-title":"Genetics"},{"key":"2022031309301527400_B13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1741-7015-12-81","article-title":"Urinary soluble urokinase receptor levels are elevated and pathogenic in patients with primary focal segmental glomerulosclerosis","volume":"12","author":"Huang","year":"2014","journal-title":"BMC Med"},{"key":"2022031309301527400_B14","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.kint.2021.02.025","article-title":"Annexin A1 alleviates kidney injury by promoting the resolution of inflammation in diabetic nephropathy","volume":"100","author":"Wu","year":"2021","journal-title":"Kidney Int"},{"key":"2022031309301527400_B15","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1681\/ASN.2010010010","article-title":"Pathologic classification of diabetic nephropathy","volume":"21","author":"Tervaert","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"2022031309301527400_B16","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1681\/ASN.2014090853","article-title":"Store-operated Ca2+ channels in mesangial cells inhibit matrix protein expression","volume":"26","author":"Wu","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"2022031309301527400_B17","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1046\/j.1523-1755.1998.00019.x","article-title":"A new model of diabetic nephropathy with progressive renal impairment in the transgenic (mRen-2)27 rat (TGR)","volume":"54","author":"Kelly","year":"1998","journal-title":"Kidney Int"},{"key":"2022031309301527400_B18","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/1753-0407.13077","article-title":"Interstitial eosinophilic infiltration in diabetic nephropathy is indicative of poor prognosis, with no therapy benefit from steroid","volume":"12","author":"Wu","year":"2020","journal-title":"J Diabetes"},{"key":"2022031309301527400_B19","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1136\/annrheumdis-2018-213028","article-title":"Increased autophagy is cytoprotective against podocyte injury induced by antibody and interferon-\u03b1 in lupus nephritis","volume":"77","author":"Qi","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2022031309301527400_B20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1365-2818.1979.tb00149.x","article-title":"Determination of membrane thickness distribution from orthogonal intercepts","volume":"115","author":"Jensen","year":"1979","journal-title":"J Microsc"},{"key":"2022031309301527400_B21","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1152\/japplphysiol.01096.2012","article-title":"Mitochondrial morphology, topology, and membrane interactions in skeletal muscle: a quantitative three-dimensional electron microscopy study","volume":"114","author":"Picard","year":"2013","journal-title":"J Appl Physiol (1985)"},{"key":"2022031309301527400_B22","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.2337\/dc19-0100","article-title":"High-coverage targeted lipidomics reveals novel serum lipid predictors and lipid pathway dysregulation antecedent to type 2 diabetes onset in normoglycemic Chinese adults","volume":"42","author":"Lu","year":"2019","journal-title":"Diabetes Care"},{"key":"2022031309301527400_B23","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.cmet.2020.06.016","article-title":"Omics-driven systems interrogation of metabolic dysregulation in COVID-19 pathogenesis","volume":"32","author":"Song","year":"2020","journal-title":"Cell Metab"},{"key":"2022031309301527400_B24","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1039\/b913353d","article-title":"Toward one step analysis of cellular lipidomes using liquid chromatography coupled with mass spectrometry: application to Saccharomyces cerevisiae and Schizosaccharomyces pombe lipidomics","volume":"6","author":"Shui","year":"2010","journal-title":"Mol Biosyst"},{"key":"2022031309301527400_B25","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1016\/j.chroma.2011.05.011","article-title":"Derivatization-independent cholesterol analysis in crude lipid extracts by liquid chromatography\/mass spectrometry: applications to a rabbit model for atherosclerosis","volume":"1218","author":"Shui","year":"2011","journal-title":"J Chromatogr A"},{"key":"2022031309301527400_B26","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.2337\/db16-1237","article-title":"MICU1 alleviates diabetic cardiomyopathy through mitochondrial Ca(2+)-dependent antioxidant response","volume":"66","author":"Ji","year":"2017","journal-title":"Diabetes"},{"key":"2022031309301527400_B27","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/ki.2013.462","article-title":"Regulation of lipid accumulation by AMP-activated kinase [corrected] in high fat diet-induced kidney injury","volume":"85","author":"Decl\u00e8ves","year":"2014","journal-title":"Kidney Int"},{"key":"2022031309301527400_B28","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1161\/CIRCULATIONAHA.118.039345","article-title":"Novel role for the AnxA1-Fpr2\/ALX signaling axis as a key regulator of platelet function to promote resolution of inflammation","volume":"140","author":"Senchenkova","year":"2019","journal-title":"Circulation"},{"key":"2022031309301527400_B29","article-title":"Anxa1 in smooth muscle cells protects against acute aortic dissection","author":"Zhou","journal-title":"Cardiovasc Res"},{"key":"2022031309301527400_B30","doi-asserted-by":"crossref","first-page":"e131849","DOI":"10.1172\/jci.insight.131849","article-title":"C3a receptor blockade protects podocytes from injury in diabetic nephropathy","volume":"5","author":"Morigi","year":"2020","journal-title":"JCI Insight"},{"key":"2022031309301527400_B31","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.acthis.2017.03.001","article-title":"A simple ImageJ macro tool for analyzing mitochondrial network morphology in mammalian cell culture","volume":"119","author":"Valente","year":"2017","journal-title":"Acta Histochem"},{"key":"2022031309301527400_B32","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1681\/ASN.V1261197","article-title":"PPARalpha gene expression in the developing rat kidney: role of glucocorticoids","volume":"12","author":"Djouadi","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"2022031309301527400_B33","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.cmet.2009.03.012","article-title":"AMPK: an emerging drug target for diabetes and the metabolic syndrome","volume":"9","author":"Zhang","year":"2009","journal-title":"Cell Metab"},{"key":"2022031309301527400_B34","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1681\/ASN.2011010026","article-title":"AMPK mediates the initiation of kidney disease induced by a high-fat diet","volume":"22","author":"Decl\u00e8ves","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"2022031309301527400_B35","doi-asserted-by":"crossref","first-page":"F617","DOI":"10.1152\/ajprenal.00278.2006","article-title":"A role for AMP-activated protein kinase in diabetes-induced renal hypertrophy","volume":"292","author":"Lee","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"2022031309301527400_B36","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1038\/nm.3363","article-title":"Renal tubular Sirt1 attenuates diabetic albuminuria by epigenetically suppressing Claudin-1 overexpression in podocytes","volume":"19","author":"Hasegawa","year":"2013","journal-title":"Nat Med"},{"key":"2022031309301527400_B37","doi-asserted-by":"crossref","first-page":"e12763","DOI":"10.1111\/cpr.12763","article-title":"Crosstalk between tubular epithelial cells and glomerular endothelial cells in diabetic kidney disease","volume":"53","author":"Chen","year":"2020","journal-title":"Cell Prolif"},{"key":"2022031309301527400_B38","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1475-2891-13-17","article-title":"Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications--a review","volume":"13","author":"Grygiel-G\u00f3rniak","year":"2014","journal-title":"Nutr J"},{"key":"2022031309301527400_B39","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/mnfr.201400399","article-title":"Ursolic acid improves lipid and glucose metabolism in high-fat-fed C57BL\/6J mice by activating peroxisome proliferator-activated receptor alpha and hepatic autophagy","volume":"59","author":"Jia","year":"2015","journal-title":"Mol Nutr Food Res"},{"key":"2022031309301527400_B40","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/sj.ki.5000209","article-title":"PPARalpha agonist fenofibrate improves diabetic nephropathy in db\/db mice","volume":"69","author":"Park","year":"2006","journal-title":"Kidney Int"},{"key":"2022031309301527400_B41","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/ki.2010.530","article-title":"Fenofibrate, a PPAR\u03b1 agonist, has renoprotective effects in mice by enhancing renal lipolysis","volume":"79","author":"Tanaka","year":"2011","journal-title":"Kidney Int"},{"key":"2022031309301527400_B42","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0041-008X(90)90334-Q","article-title":"Changes in hepatic lipid metabolism associated with lipid accumulation and its reversal in rats given the peroxisome proliferator LY171883","volume":"106","author":"Foxworthy","year":"1990","journal-title":"Toxicol Appl Pharmacol"},{"key":"2022031309301527400_B43","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.bbalip.2009.10.006","article-title":"Lipid homeostasis, lipotoxicity and the metabolic syndrome","volume":"1801","author":"Unger","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"2022031309301527400_B44","doi-asserted-by":"crossref","first-page":"4888","DOI":"10.1172\/JCI66218","article-title":"AMPK dysregulation promotes diabetes-related reduction of superoxide and mitochondrial function","volume":"123","author":"Dugan","year":"2013","journal-title":"J Clin Invest"},{"key":"2022031309301527400_B45","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.bbrc.2005.12.011","article-title":"AMPK activation increases fatty acid oxidation in skeletal muscle by activating PPARalpha and PGC-1","volume":"340","author":"Lee","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"2022031309301527400_B46","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1128\/MCB.02222-06","article-title":"Leptin stimulates fatty acid oxidation and peroxisome proliferator-activated receptor alpha gene expression in mouse C2C12 myoblasts by changing the subcellular localization of the alpha2 form of AMP-activated protein kinase","volume":"27","author":"Suzuki","year":"2007","journal-title":"Mol Cell Biol"},{"key":"2022031309301527400_B47","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1172\/JCI124635","article-title":"Annexin A1 drives macrophage skewing to accelerate muscle regeneration through AMPK activation","volume":"130","author":"McArthur","year":"2020","journal-title":"J Clin Invest"},{"key":"2022031309301527400_B48","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nri.2016.70","article-title":"A guide to immunometabolism for immunologists","volume":"16","author":"O\u2019Neill","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"2022031309301527400_B49","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.immuni.2013.04.005","article-title":"Metabolic pathways in immune cell activation and quiescence","volume":"38","author":"Pearce","year":"2013","journal-title":"Immunity"},{"key":"2022031309301527400_B50","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nm.3762","article-title":"Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development","volume":"21","author":"Kang","year":"2015","journal-title":"Nat Med"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/70\/10\/2192\/628601\/db210050.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/70\/10\/2192\/628601\/db210050.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T12:42:21Z","timestamp":1667392941000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/70\/10\/2192\/137896\/The-Attenuation-of-Diabetic-Nephropathy-by-Annexin"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,8]]},"references-count":50,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,6,8]]},"published-print":{"date-parts":[[2021,10,1]]}},"URL":"https:\/\/doi.org\/10.2337\/db21-0050","relation":{"has-preprint":[{"id-type":"doi","id":"10.2337\/figshare.14727453","asserted-by":"object"},{"id-type":"doi","id":"10.2337\/figshare.14727453.v2","asserted-by":"object"},{"id-type":"doi","id":"10.2337\/figshare.14727453.v1","asserted-by":"object"}]},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,8]]}}}